CCL21 injection into pancreatic tumors has been shown to be beneficial by inhibiting tumor growth, decreasing the size of distant metastasis, increasing T cell infiltrate and even enhancing antigen cross-presentation by DC [103]. This evidence concerns the gene CCL21 and pancreatic neoplasm.